• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    180.08 Down 4.50(2.44%) 4:00PM EDT
    |After Hours : 180.82 Up 0.74 (0.41%) 4:58PM EDT
    Add to Portfolio
    Prev Close:184.58
    Open:183.04
    Bid:176.50 x 100
    Ask:182.90 x 200
    1y Target Est:213.55
    Beta:1.19
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:179.52 - 183.98
    52wk Range:147.81 - 203.30
    Volume:1,644,938
    Avg Vol (3m):1,274,240
    Market Cap:35.95B
    P/E (ttm):55.24
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 2.44%35.95B
    AMGNDown 0.74%127.61B
    BAXDown 0.52%38.67B

    Key Statistics

    Forward P/E (1 yr):24.67
    P/S (ttm):16.70
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.87
    Quarterly EPS Est (Jun-15) :1.41
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.28

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback